LL-37 is a synthetic peptide which plays an important part in the body’s ability to fight infection; it shows a broad spectrum ability to fight bacteria, viruses, and fungi. It is believed to be effective in disrupting both bacterial and viral membranes and has been studied with promising results in RSV, Influenza A, Candida albicans, HIV-1, and staph epidermidis. It may also be beneficial for antibiotic resistant infections and is being considered closely for this application.

LL-37 is prescribed as a subcutaneous injection administered generally administered for 4-6 weeks.

Click to View the Professional Monograph PDF